NYSTATIN TOPICAL POWDER

NYSTATIN TOPICAL POWDER was reported 32 times

NYSTATIN TOPICAL POWDER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ISOIMMUNE HAEMOLYTIC DISEASE 1 0.0263
1 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 1 0.0182
2 POST PROCEDURAL DRAINAGE 1 0.0069
3 INFECTIVE GLOSSITIS 1 0.0064
4 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
5 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
6 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
7 SKIN CANDIDA 1 0.0019
8 INCISION SITE COMPLICATION 1 0.0012
9 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
10 GASTROINTESTINAL OEDEMA 1 0.0006
11 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
12 BONE MARROW DISORDER 1 0.0003
13 FAILURE TO THRIVE 1 0.0002
14 URINE ODOUR ABNORMAL 1 0.0002
15 FOREIGN BODY SENSATION IN EYES 1 0.0002
16 TERMINAL STATE 1 0.0001
17 POSTOPERATIVE WOUND INFECTION 1 0.0001
18 PROCEDURAL COMPLICATION 1 0.0001
19 URINE OUTPUT DECREASED 1 0.0001
20 GRIP STRENGTH DECREASED 1 0.0001
21 HYPERBILIRUBINAEMIA 1 0.0001
22 TENDERNESS 1 0.0001
23 FOLLICULITIS 1 0.0001
24 FLUID OVERLOAD 1 0.0001
25 FEMUR FRACTURE 2 0.0001
26 HEAD INJURY 2 0.0001
27 VENTRICULAR TACHYCARDIA 1 0.0001
28 COAGULOPATHY 1 0.0001
29 CANDIDA INFECTION 1 0.0001
30 POST PROCEDURAL COMPLICATION 1 0.0001
31 ACUTE RESPIRATORY FAILURE 1 0.0001
32 HALLUCINATION, VISUAL 1 0.0000
33 LIVER FUNCTION TEST INCREASED 1 0.0000
34 CHROMATURIA 1 0.0000
35 HYPOGLYCAEMIA 2 0.0000
36 HYPOPHAGIA 1 0.0000
37 BLOOD BILIRUBIN INCREASED 1 0.0000
38 LABORATORY TEST ABNORMAL 1 0.0000
39 PLEURAL EFFUSION 2 0.0000
40 DELIRIUM 1 0.0000
41 HEART RATE DECREASED 1 0.0000
42 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
43 DYSURIA 1 0.0000
44 DYSPNOEA EXERTIONAL 1 0.0000
45 CARDIAC FAILURE 2 0.0000
46 LOSS OF CONSCIOUSNESS 3 0.0000
47 THERAPY NON-RESPONDER 1 0.0000
48 SKIN DISCOLOURATION 1 0.0000
49 DRY EYE 1 0.0000
50 CELLULITIS 1 0.0000
51 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
52 SEPSIS 2 0.0000
53 THROMBOCYTOPENIA 2 0.0000
54 EYE PAIN 1 0.0000
55 HERPES ZOSTER 1 0.0000
56 EYE IRRITATION 1 0.0000
57 BLOOD CREATININE INCREASED 1 0.0000
58 THERAPY INTERRUPTED 1 0.0000
59 RESPIRATORY FAILURE 1 0.0000
60 BRONCHITIS 1 0.0000
61 HALLUCINATION 1 0.0000
62 INJECTION SITE BRUISING 1 0.0000
63 CONFUSIONAL STATE 2 0.0000
64 DRY MOUTH 1 0.0000
65 GASTROINTESTINAL DISORDER 1 0.0000
66 DRUG INTOLERANCE 1 0.0000
67 ATRIAL FIBRILLATION 1 0.0000
68 SINUSITIS 1 0.0000
69 HAEMOGLOBIN DECREASED 1 0.0000
70 ERYTHEMA 2 0.0000
71 PNEUMONIA 3 0.0000
72 FALL 3 0.0000
73 INFLUENZA 1 0.0000
74 PYREXIA 3 0.0000
75 SEIZURE 1 0.0000
76 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
77 ASTHENIA 3 0.0000
78 HYPERHIDROSIS 1 0.0000
79 RENAL FAILURE 1 0.0000
80 VISION BLURRED 1 0.0000
81 PRODUCT DOSE OMISSION ISSUE 2 0.0000
82 TREMOR 1 0.0000
83 MYALGIA 1 0.0000
84 URINARY TRACT INFECTION 1 0.0000
85 CHEST PAIN 1 0.0000
86 ANAEMIA 1 0.0000
87 HYPOTENSION 1 0.0000
88 CONSTIPATION 1 0.0000
89 DEPRESSION 1 0.0000
90 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
91 WEIGHT DECREASED 1 0.0000
92 PAIN IN EXTREMITY 1 0.0000
93 INJECTION SITE PAIN 1 0.0000
94 PRURITUS 1 0.0000
95 NAUSEA 2 0.0000
96 ARTHRALGIA 1 0.0000
97 RASH 1 0.0000
98 MALAISE 1 0.0000
99 PAIN 1 0.0000
100 DIARRHOEA 1 0.0000
101 DRUG INEFFECTIVE 2 0.0000
102 FATIGUE 1 0.0000